Our test menu has expanded, again! This month, we have added 11 new Spotlight™ panels, three new Focus™ panels, and one new Comprehensive panel, across multiple disorder types.
Photo Source: Angelman Syndrome Foundation
Angelman syndrome is a genetic condition that causes developmental and intellectual disabilities. Common features seen in Angelman syndrome are seizures, ataxia, unique facial features, small head size (microcephaly), and behavioral differences.
Topics: Developmental Delay
This month, we are happy to announce we have added another 11 tests to our growing catalog of Courtagen Spotlight™ Panels. These small (3 to 50 genes) panels provide clinicians with a targeted approach to genetic testing, and are best used when a patient's symptomatology is discernible. Each Spotlight Panel contains addresses a group of disorders with overlapping symptoms, making test selection clear and straightforward.
We are happy to announce the addition of 10 new tests to our Spotlight™ Panelline, which provides clinicians a targeted approach to genetic testing when a patient's symptomatology is discernible. Each Spotlight Panel contains between approximately 3 to 50 genes selected to address a group of disorders with overlapping symptoms, making test selection clear and straightforward.
We are excited to announce that we received a Notice of Allowance from the United States Patent and Trademark Office for a patent that uses a personalized medicine approach to match genetic markers for chronic pain with therapeutic drugs, including the cannabis-derived compound cannabidiol.
Primary hyperparathyroidism is a disorder of the parathyroid glands caused by overproduction of parathyroid hormone (PTH). This overproduction leads to high blood calcium and causes symptoms such as muscle weakness, fatigue, depression, bone and joint pain, nausea, vomiting, constipation, confusion or impaired thinking and memory, kidney stones, frequent urination, and osteoporosis.
We are happy to announce that we have added 17 new gene panels to our Spotlight line of tests. These new tests will expand our menu by 65%, offering new testing options in neurology, endocrinology, epilepsy, developmental delay, mitochondrial disease, and other disease areas.
Autism spectrum disorder (ASD) and intellectual disability (ID) have long been considered clinically distinct conditions, but a closer look suggests the two may be linked and share an underlying genetic cause.